Literature DB >> 34035743

Current Understanding of Risk for Nonalcoholic Steatohepatitis and Progressive Fibrosis.

Mazen Noureddin1.   

Abstract

Entities:  

Year:  2020        PMID： 34035743      PMCID： PMC8132646     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  11 in total

1.  Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity.

Authors:  Giovanni Musso; Roberto Gambino; Maurizio Cassader; Gianfranco Pagano
Journal:  Ann Med       Date:  2010-11-02       Impact factor: 4.709

2.  Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease.

Authors:  Paul Angulo; David E Kleiner; Sanne Dam-Larsen; Leon A Adams; Einar S Bjornsson; Phunchai Charatcharoenwitthaya; Peter R Mills; Jill C Keach; Heather D Lafferty; Alisha Stahler; Svanhildur Haflidadottir; Flemming Bendtsen
Journal:  Gastroenterology       Date:  2015-04-29       Impact factor: 22.682

3.  Diet Associations With Nonalcoholic Fatty Liver Disease in an Ethnically Diverse Population: The Multiethnic Cohort.

Authors:  Mazen Noureddin; Shira Zelber-Sagi; Lynne R Wilkens; Jacqueline Porcel; Carol J Boushey; Loïc Le Marchand; Hugo R Rosen; Veronica Wendy Setiawan
Journal:  Hepatology       Date:  2020-02-14       Impact factor: 17.425

4.  Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD.

Authors:  Hannes Hagström; Patrik Nasr; Mattias Ekstedt; Ulf Hammar; Per Stål; Rolf Hultcrantz; Stergios Kechagias
Journal:  J Hepatol       Date:  2017-08-10       Impact factor: 25.083

5.  Prevalence of chronic liver disease and cirrhosis by underlying cause in understudied ethnic groups: The multiethnic cohort.

Authors:  Veronica Wendy Setiawan; Daniel O Stram; Jacqueline Porcel; Shelly C Lu; Loïc Le Marchand; Mazen Noureddin
Journal:  Hepatology       Date:  2016-07-17       Impact factor: 17.425

6.  17-Beta Hydroxysteroid Dehydrogenase 13 Is a Hepatic Retinol Dehydrogenase Associated With Histological Features of Nonalcoholic Fatty Liver Disease.

Authors:  Yanling Ma; Olga V Belyaeva; Philip M Brown; Koji Fujita; Katherine Valles; Suman Karki; Ynto S de Boer; Christopher Koh; Yanhua Chen; Xiaomeng Du; Samuel K Handelman; Vincent Chen; Elizabeth K Speliotes; Cara Nestlerode; Emmanuel Thomas; David E Kleiner; Joseph M Zmuda; Arun J Sanyal; Natalia Y Kedishvili; T Jake Liang; Yaron Rotman
Journal:  Hepatology       Date:  2019-03-05       Impact factor: 17.425

Review 7.  Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis.

Authors:  Parambir S Dulai; Siddharth Singh; Janki Patel; Meera Soni; Larry J Prokop; Zobair Younossi; Giada Sebastiani; Mattias Ekstedt; Hannes Hagstrom; Patrik Nasr; Per Stal; Vincent Wai-Sun Wong; Stergios Kechagias; Rolf Hultcrantz; Rohit Loomba
Journal:  Hepatology       Date:  2017-03-31       Impact factor: 17.425

8.  Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management.

Authors:  Stuart McPherson; Tim Hardy; Elsbeth Henderson; Alastair D Burt; Christopher P Day; Quentin M Anstee
Journal:  J Hepatol       Date:  2014-12-01       Impact factor: 25.083

9.  Coffee Drinking and Alcoholic and Nonalcoholic Fatty Liver Diseases and Viral Hepatitis in the Multiethnic Cohort.

Authors:  Veronica Wendy Setiawan; Jacqueline Porcel; Pengxiao Wei; Daniel O Stram; Nabil Noureddin; Shelly C Lu; Loïc Le Marchand; Mazen Noureddin
Journal:  Clin Gastroenterol Hepatol       Date:  2017-03-11       Impact factor: 11.382

Review 10.  Women Have a Lower Risk of Nonalcoholic Fatty Liver Disease but a Higher Risk of Progression vs Men: A Systematic Review and Meta-analysis.

Authors:  Maya Balakrishnan; Parth Patel; Sydney Dunn-Valadez; Cecilia Dao; Vinshi Khan; Hiba Ali; Laith El-Serag; Ruben Hernaez; Amy Sisson; Aaron P Thrift; Yan Liu; Hashem B El-Serag; Fasiha Kanwal
Journal:  Clin Gastroenterol Hepatol       Date:  2020-04-30       Impact factor: 11.382
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.